Pricing Log in Create free account

C4 Therapeutics, Inc. (CCCC) vs Kyverna Therapeutics, Inc. (KYTX)

C4 Therapeutics, Inc. and Kyverna Therapeutics, Inc. are both Biotechnology companies. C4 Therapeutics, Inc. and Kyverna Therapeutics, Inc. are of similar size ($369.2M and $342.0M). Kyverna Therapeutics, Inc. has the higher net margin (0.00% vs −289.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, C4 Therapeutics, Inc. leads on 7 and Kyverna Therapeutics, Inc. on 5.

Valuation

Metric CCCC KYTX Biotechnology median
P/E n/m n/m 8.50
P/S 10.33 n/m 9.71
P/B 1.46 2.09 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 3.63 n/m 9.21
Earnings yield (36.10%) (51.85%) (33.15%)
Free cash flow yield (23.59%) (46.04%) (25.50%)

Profitability

Metric CCCC KYTX Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (318.97%) 0.00% 0.00%
Net margin (289.44%) 0.00% 0.00%
Free cash flow margin (243.71%) 0.00% 0.00%
Return on equity (48.14%) (87.24%) (56.36%)
Return on assets (30.92%) (68.40%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CCCC KYTX Biotechnology median
Revenue growth (TTM) 2.33% — 6.02%
EPS growth (last fiscal year) 16.45% (9.31%) 30.26%
Revenue growth, 5-year CAGR 1.61% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CCCC KYTX Biotechnology median
Debt to equity 0.00 0.15 0.00
Current ratio 5.45 9.06 4.72
Net debt to EBITDA 2.14 1.51 0.96

Dividend

Metric CCCC KYTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CCCC KYTX Biotechnology median
Market cap 342.01m 369.21m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack